SEC Tracker
Get the app
INGN · XBRL financial data

Inogen financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (INGN's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue83,96775,896*78,02588,76588,83480,081*82,28092,27792,39081,721*85,10995,084
Revenue from contracts with customers67,97359,404*63,09574,42574,92966,307*68,47079,17279,09068,572*72,40483,525
Cost of revenue50,20347,738*43,65446,02847,49043,792*45,90850,93651,07446,485*47,24651,812
Cost of goods and services sold42,70839,936*35,24438,32039,59235,499*38,08343,46942,92539,360*40,17744,949
Gross profit33,76428,158*34,37142,73741,34436,289*36,37241,34141,31635,236*37,86343,272
Research and development4,4896,714*6,5785,6163,5185,898*4,0345,2094,8405,316*5,0975,871
General and administrative17,01124,773*17,13118,56819,25717,622*16,23716,87118,15316,120*17,49917,673
Total operating expenses80,48557,140*50,64549,80149,13647,675*44,02847,47048,43244,542*47,19948,368
Operating income (loss)(46,721)(28,982)*(16,274)(7,064)(7,792)(11,386)*(7,656)(6,129)(7,116)(9,306)*(9,336)(5,096)
Interest income1,8011,602*1,4031,3331,0411,413*1,0291,1231,0701,163*880861
Other income (expense)(398)292*143134687(114)*356701606780*(42)231
Income tax expense (benefit)401(533)*(150)(7)(101)(330)*(97)(153)(146)(236)*(174)(154)
Net income (loss)(45,719)(26,555)*(14,578)(5,590)(5,963)(9,757)*(6,174)(4,152)(5,294)(7,127)*(8,324)(3,850)
Earnings per share, basic USD per share(1.97)(1.14)*(0.62)(0.24)(0.25)(0.41)*(0.25)(0.15)(0.20)(0.26)*(0.30)(0.14)
Earnings per share, diluted USD per share(1.97)(1.14)*(0.62)(0.24)(0.25)(0.41)*(0.25)(0.15)(0.20)(0.26)*(0.30)(0.14)
Weighted average shares, basic thousands of shares23,23123,313*23,40223,61523,75123,847*25,16426,96227,07627,177*27,32227,045
Weighted average shares, diluted thousands of shares23,23123,313*23,40223,61523,75123,847*25,16426,96227,07627,177*27,32227,045

Balance sheet

CSV

Fiscal quarters (INGN's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents124,608125,492107,44497,920105,690113,795118,893103,685106,476103,72993,11287,276
Marketable securities13,4322,97912,36119,76714,9730—18,74516,74715,84817,05918,263
Accounts receivable48,38042,24140,22336,03734,23329,56336,62338,59240,37438,86341,87446,157
Inventory24,01521,84024,60124,04823,32024,81226,27324,31325,07525,96924,99228,633
Prepaid and other current assets14,36313,84613,58912,4109,78313,12315,27316,51413,76212,60112,33212,504
Total current assets225,268207,067199,194194,791192,554185,451200,708203,121203,715198,299190,665194,136
Property and equipment, net49,52550,31649,27047,02246,59844,40041,09940,17137,33136,36233,68631,781
Right-of-use asset21,18420,33820,57519,95119,01718,29518,12017,98217,19916,50115,72814,914
Goodwill9,86910,0579,8349,76410,1709,4659,86010,70010,69510,69810,48310,395
Total assets343,696326,194315,599308,919306,172296,185308,412312,040307,009298,625285,926285,572
Accounts payable15,40813,45415,92214,99515,45916,61623,25721,90021,21620,26424,08825,252
Total current liabilities60,38272,49673,91072,18572,39676,68665,45167,06864,94463,53561,44770,864
Lease liability, non-current18,87318,27018,59518,10617,37016,59416,26715,95515,09914,31313,44312,541
Total liabilities113,066121,382123,701121,324120,768122,325110,460112,549109,834106,394103,020110,708
Accumulated deficit(90,394)(116,949)(131,527)(137,117)(143,080)(152,837)(159,011)(163,163)(168,457)(175,584)(183,908)(187,758)
Total stockholders' equity230,630204,812191,898187,595185,404173,860197,952199,491197,175192,231182,906174,864
Total liabilities and equity343,696326,194315,599308,919306,172296,185308,412312,040307,009298,625285,926285,572
Common shares outstanding (cover page) thousands of shares23,30823,32723,57723,71923,81826,53026,88727,04027,14827,23227,07526,538

Cash flows

CSV

Fiscal quarters (INGN's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(45,719)(26,555)*(14,578)(5,590)(5,963)(9,757)*(6,174)(4,152)(5,294)(7,127)*(8,324)(3,850)
Stock-based compensation1,779*(1,057)*2,4161,814*1,474*1,693*2,1472,293*1,763*1,811*1,9501,771*
Depreciation and amortization4,614*5,144*5,2655,345*5,314*5,080*5,1895,216*5,219*5,035*4,9044,697*
Net cash from operating activities2,185*(3,148)*(4,749)6,689*6,992*(3,018)*(16,790)4,350*2,167*(943)*(6,685)2,946*
Purchases of property and equipment708*1,394*1,31050*1,671*329*292684*568*979*210711*
Net cash from investing activities(45,793)*4,128*(13,444)(12,376)*305*11,540*(2,038)(22,573)*(82)*(1,516)*(1,975)(3,134)*
Proceeds from issuing common stock——————27,2100*0*0*——
Share repurchases——————————1,8745,624*
Net cash from financing activities448*(14)*285(201)*441*(260)*23,9510*418*(187)*(2,123)(5,624)*
Net change in cash(43,079)*884*(18,048)(5,965)*7,802*8,134*5,124(17,582)*2,800*(2,739)*(10,610)(5,829)*

Compare with peers

SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Inogen87,27695,0842,946*26.5M— 10-QJun 30, 2026
Utah Medical Products87,5288,5291,383*3.2M— 10-QJun 30, 2026
Orasure Technologies160,58230,639(9,921)*69.0M16.2 quarters 10-QJun 30, 2026
Tactile Systems Technology75,11091,85811,978*22.4M— 10-QSep 30, 2026
Electromed20,45019,417*2,994*8.4M— 10-KJun 30, 2026
SkinHealth Systems206,07472,1132,671*130.1M— 10-QJun 30, 2026
Cerus16,35057,7143,007*202.0M— 10-QSep 30, 2026
SANUWAVE Health9,3769,739425*8.6M— 10-QJun 30, 2026
Sight Sciences79,75323,388(5,663)*55.1M14.1 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.